These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32764682)

  • 1. NanoBRET binding assay for histamine H
    Grätz L; Tropmann K; Bresinsky M; Müller C; Bernhardt G; Pockes S
    Sci Rep; 2020 Aug; 10(1):13288. PubMed ID: 32764682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homogeneous, Real-Time NanoBRET Binding Assays for the Histamine H
    Mocking TAM; Verweij EWE; Vischer HF; Leurs R
    Mol Pharmacol; 2018 Dec; 94(6):1371-1381. PubMed ID: 30249614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Horizons on Molecular Pharmacology Applied to Drug Discovery: When Resonance Overcomes Radioligand Binding.
    Pernomian L; Gomes MS; Moreira JD; da Silva CHTP; Rosa JMC; Cardoso CRB
    Curr Radiopharm; 2017; 10(1):16-20. PubMed ID: 28183248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of a new series of carbamoylguanidines reveals potent agonism at the H
    Biselli S; Bresinsky M; Tropmann K; Forster L; Honisch C; Buschauer A; Bernhardt G; Pockes S
    Eur J Med Chem; 2021 Mar; 214():113190. PubMed ID: 33548637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [(3) H]UR-DE257: development of a tritium-labeled squaramide-type selective histamine H2 receptor antagonist.
    Baumeister P; Erdmann D; Biselli S; Kagermeier N; Elz S; Bernhardt G; Buschauer A
    ChemMedChem; 2015 Jan; 10(1):83-93. PubMed ID: 25320025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRET- and fluorescence anisotropy-based assays for real-time monitoring of ligand binding to M
    Grätz L; Laasfeld T; Allikalt A; Gruber CG; Pegoli A; Tahk MJ; Tsernant ML; Keller M; Rinken A
    Biochim Biophys Acta Mol Cell Res; 2021 Mar; 1868(3):118930. PubMed ID: 33347921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a G Protein-Biased Radioligand for the Histamine H
    Tropmann K; Höring C; Plank N; Pockes S
    J Med Chem; 2020 Nov; 63(21):13090-13102. PubMed ID: 33108724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of Receptor Heteromers Using NanoBRET Ligand Binding.
    Johnstone EKM; See HB; Abhayawardana RS; Song A; Rosengren KJ; Hill SJ; Pfleger KDG
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NanoBRET ligand binding at a GPCR under endogenous promotion facilitated by CRISPR/Cas9 genome editing.
    White CW; Johnstone EKM; See HB; Pfleger KDG
    Cell Signal; 2019 Feb; 54():27-34. PubMed ID: 30471466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRET-based β-arrestin2 recruitment to the histamine H1 receptor for investigating antihistamine binding kinetics.
    Bosma R; Moritani R; Leurs R; Vischer HF
    Pharmacol Res; 2016 Sep; 111():679-687. PubMed ID: 27468652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine H
    Pockes S; Tropmann K
    Future Med Chem; 2021 Jun; 13(12):1073-1081. PubMed ID: 33906421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring the rapid kinetics of receptor-ligand interactions in live cells using NanoBRET.
    Suchankova A; Harris M; Ladds G
    Methods Cell Biol; 2021; 166():1-14. PubMed ID: 34752328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel BRET-based binding assay for interaction studies of relaxin family peptide receptor 3 with its ligands.
    Wang JH; Shao XX; Hu MJ; Wei D; Liu YL; Xu ZG; Guo ZY
    Amino Acids; 2017 May; 49(5):895-903. PubMed ID: 28161795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insertion of Nanoluc into the Extracellular Loops as a Complementary Method To Establish BRET-Based Binding Assays for GPCRs.
    Grätz L; Müller C; Pegoli A; Schindler L; Bernhardt G; Littmann T
    ACS Pharmacol Transl Sci; 2022 Nov; 5(11):1142-1155. PubMed ID: 36407949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UR-DEBa242: A Py-5-Labeled Fluorescent Multipurpose Probe for Investigations on the Histamine H
    Bartole E; Grätz L; Littmann T; Wifling D; Seibel U; Buschauer A; Bernhardt G
    J Med Chem; 2020 May; 63(10):5297-5311. PubMed ID: 32420741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescent ligands for the histamine H2 receptor: synthesis and preliminary characterization.
    Malan SF; van Marle A; Menge WM; Zuliani V; Hoffman M; Timmerman H; Leurs R
    Bioorg Med Chem; 2004 Dec; 12(24):6495-503. PubMed ID: 15556766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimeric carbamoylguanidine-type histamine H2 receptor ligands: A new class of potent and selective agonists.
    Kagermeier N; Werner K; Keller M; Baumeister P; Bernhardt G; Seifert R; Buschauer A
    Bioorg Med Chem; 2015 Jul; 23(14):3957-69. PubMed ID: 25639885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-Component Mechanism of H2 Relaxin Binding to RXFP1 through NanoBRET Kinetic Analysis.
    Hoare BL; Bruell S; Sethi A; Gooley PR; Lew MJ; Hossain MA; Inoue A; Scott DJ; Bathgate RAD
    iScience; 2019 Jan; 11():93-113. PubMed ID: 30594862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist Binding and G Protein Coupling in Histamine H
    Conrad M; Söldner CA; Miao Y; Sticht H
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A NanoBRET-Based Binding Assay for Smoothened Allows Real-time Analysis of Ligand Binding and Distinction of Two Binding Sites for BODIPY-cyclopamine.
    Kozielewicz P; Bowin CF; Turku A; Schulte G
    Mol Pharmacol; 2020 Jan; 97(1):23-34. PubMed ID: 31707356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.